Chew on This: Not All First Finger Foods Are Created Equal

Nicol Awadalla1, Tammy Pham1, Ruth Milanaik1

  • 11 Cohen Children's Medical Center of New York, Lake Success, NY, USA.

Clinical Pediatrics
|October 10, 2017
PubMed

Insights

Few first finger foods (FFFs) meet American Academy of Pediatrics guidelines. Some FFF products raise safety concerns and may pose choking hazards if not stored properly.

Area of Science:

  • Pediatric Nutrition
  • Food Safety

Background:

  • The American Academy of Pediatrics (AAP) provides guidelines for introducing first finger foods (FFFs).
  • Compliance of commercially available FFF products with these recommendations is not well-understood.

Purpose of the Study:

  • To evaluate the compliance of marketed FFF products with AAP recommendations.
  • To assess the safety of FFF products using adult testers.

Main Methods:

  • 41 adult testers evaluated FFF products for safety and dissolvability.
  • Product characteristics, safety comments, and dissolution times were recorded.

Main Results:

  • Only 2 out of the tested FFF products met all AAP criteria.
  • Safety concerns were identified for 2 additional products.
  • One product's dissolvability significantly changed after removal from original packaging, indicating a potential choking hazard.

Conclusions:

  • Consumers should verify FFF product compliance with AAP guidelines, as marketing does not guarantee it.
  • Improper storage of FFFs can alter consistency and increase choking risks.
  • Further research is needed to inform regulations for FFF labeling and marketing.

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
197
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
199
The Tongue and Taste Buds00:49

The Tongue and Taste Buds

The surface of the tongue is covered with various small bumps called papillae, which either distribute what has been ingested (filiform papillae) or contain the sensory taste (or gustatory) receptor cells (fungiform, circumvallate, and foliate papillae). Embedded within each taste-related papilla are the taste buds—clusters of 30 to 100 gustatory receptor cells.
41.3K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
221
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
325
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
356